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Abstract
Background: The term severe acute respiratory infection (SARI) encompasses a heterogeneous group of respiratory
illnesses. Grading the severity of SARI is currently reliant on indirect disease severity measures such as respiratory
and heart rate, and the need for oxygen or intensive care. With the lungs being the primary organ system involved
in SARI, chest radiographs (CXRs) are potentially useful for describing disease severity. Our objective was to develop
and validate a SARI CXR severity scoring system.
Methods: We completed validation within an active SARI surveillance project, with SARI defined using the World Health
Organization case definition of an acute respiratory infection with a history of fever, or measured fever of ≥ 38 °C; and
cough; and with onset within the last 10 days; and requiring hospital admission. We randomly selected 250 SARI cases.
Admission CXR findings were categorized as: 1 = normal; 2 = patchy atelectasis and/or hyperinflation and/or bronchial
wall thickening; 3 = focal consolidation; 4 = multifocal consolidation; and 5 = diffuse alveolar changes.
Initially, four radiologists scored CXRs independently. Subsequently, a pediatrician, physician, two residents, two medical
students, and a research nurse independently scored CXR reports. Inter-observer reliability was determined using a
weighted Kappa (κ) for comparisons between radiologists; radiologists and clinicians; and clinicians. Agreement was
defined as moderate (κ > 0.4–0.6), good (κ > 0.6–0.8) and very good (κ > 0.8–1.0).
Results: Agreement between the two pediatric radiologists was very good (κ = 0.83, 95 % CI 0.65–1.00) and between the
two adult radiologists was good (κ = 0.75, 95 % CI 0.57–0. 93).
Agreement of the clinicians with the radiologists was moderate-to-good (pediatrician:κ = 0.65; pediatric resident:κ = 0.69;
physician:κ = 0.68; resident:κ = 0.67; research nurse:κ = 0.49, medical students: κ = 0.53 and κ = 0.56).
Agreement between clinicians was good-to-very good (pediatrician vs. physician:κ = 0.85; vs. pediatric resident:κ = 0.81;
vs. medicine resident:κ = 0.76; vs. research nurse:κ = 0.75; vs. medical students:κ = 0.63 and 0.66).
Following review of discrepant CXR report scores by clinician pairs, κ values for radiologist-clinician agreement ranged
from 0.59 to 0.70 and for clinician-clinician agreement from 0.97 to 0.99.
Conclusions: This five-point CXR scoring tool, suitable for use in poorly- and well-resourced settings and by clinicians of
varying experience levels, reliably describes SARI severity. The resulting numerical data enables epidemiological
comparisons of SARI severity between different countries and settings.
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Background
Hospital-based surveillance for severe acute respiratory
infection (SARI) has been implemented globally [1, 2].
The term SARI encompasses a heterogeneous group of
respiratory illness syndromes. Clinical features of these
syndromes overlap, with a broad spectrum of disease
severity, ranging from overnight hospital admission to
disease that causes death despite intensive care. Recent
descriptions of SARI have highlighted this spectrum of
severity and identified population subgroups at increased
risk of severe or fatal disease, for example pregnant
women, children with high-risk medical conditions, and
individuals with diabetes or obesity [3–6].
However, grading the clinical severity of SARI in a
manner that allows regional or temporal comparisons
has proven difficult. Currently we are reliant on indirect
disease severity measures, for example respiratory rate,
presence of indrawing, hemoglobin oxygen saturation,
use of oxygen, intensive care unit admission and length
of hospitalization. The availability of such measures varies
extensively worldwide due to differences in healthcare-
seeking behavior, criteria for hospitalization, the length of
hospitalization, and availability of oxygen and intensive
care. In both developing and developed countries, chest
radiographs are one of the more standardized pieces of
data collected in epidemiological studies of acute respira-
tory infections [7]. For example, chest radiographs are a
component of the contemporary global epidemiological
study of severe pneumonia in children: the Pneumonia
Etiology Research for Child Health project, being
conducted in South Africa, Zambia, Kenya, the Gambia,
Mali, Thailand, and Bangladesh [8].
Included among the 15 recommendations made by the
World Health Organization (WHO) from their review of
the functioning of the 2005 International Health Regula-
tions in relation to the 2009 H1N1 pandemic, was the
need to develop and apply measures to assess the sever-
ity of a pandemic beyond the number of cases and
deaths [9]. With the lungs being the primary organ
system involved in SARI, chest radiographs (CXRs) are
potentially useful for describing disease severity. Clinic-
ally, physicians use CXRs to define the extent of lung in-
volvement and the presence of pulmonary complications,
yet currently our ability to utilize this information to de-
fine SARI severity or to compare severity between popula-
tion subgroups, is limited.
To date, the use of CXRs has focused primarily on the
diagnosis of specific syndromes, in particular pneumonia,
and in informing therapeutic decisions for individual pa-
tients, for example antibiotic treatment. This is despite
poor inter-observer agreement in use of a CXR to deter-
mine the presence of pneumonia or to indicate a bacterial
versus a viral etiology (Kappa values of 0.46 for pneumo-
nia and 0.27–0.38 for viral vs. bacterial etiology) [10–12].
In an attempt to improve the consistency of CXR in-
terpretation between epidemiological studies, the WHO
standardized the interpretation of CXRs for the diagno-
sis of pneumonia in children [7]. However, the utility of
WHO’s CXR assessment method, when applied to clin-
ical studies of SARI, has been questioned due to a low
sensitivity for diagnosing pneumonia [13]. Additionally,
there are inherent limitations in assessing severity with a
tool that dichotomizes CXRs only on whether or not
alveolar consolidation is present.
Case series of SARI from the recent H1N1 influenza
pandemic have provided a more complete description of
the specific associated radiological features, which in-
clude rapidity of progression, broad regions of affected
lung, extensive infiltrates, and ground glass changes
[14–17]. Being able to quantify the extent of radio-
graphic changes in a systematic manner would allow for
better and more objective assessment and comparison of
rates and severity of SARI between studies, over time,
and in different global regions; and potentially enable a
better understanding of prognosis.
For large surveillance projects, a CXR scoring system
usually cannot demand significant additional resources,
such as independent specialist radiologists to review all
CXRs. One potential approach is to utilize the informa-
tion contained in the report of the CXR that a radiolo-
gist produces as a component of a patient’s hospital
medical record, allowing non-radiologist clinicians to
use this information to assess severity. However, because
of the individual variability in how different radiologists
report CXRs, an assessment of the validity of this
approach is necessary.
Our objective was to assess the validity of a standard-
ized scoring system for reviewing CXR reports in
patients hospitalized with SARI. If valid, such an ap-
proach would have the potential to allow the inclusion
of CXR data in epidemiological studies of SARI world-
wide, in a cost- and time-efficient manner, and form an
integral part of overall severity assessment for seasonal
and pandemic influenza.
Methods
Study design and setting
We described the CXR abnormalities of a case series of
children and adults hospitalized with a SARI, as defined
by the WHO (Fig. 1) [2]. We identified SARI cases by ac-
tive surveillance within a geographically defined region of
Auckland, New Zealand (latitude 36°S). This active
surveillance is a component of the Southern Hemisphere
Influenza Vaccine Effectiveness Research and Surveillance
(SHIVERS) project [18]. We obtained ethical approval
from the Northern A Health and Disability Ethics
Committee (NTX/11/11/102 AM02). The Ethics com-
mittee considered written consent unnecessary for this
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collection of non-sensitive data from routine in-hospital
clinical management and diagnostic testing. We obtained
verbal consent from all participants or, in the case of mi-
nors, from their caregivers. Verbal explanation of the rea-
son for collection of this additional information and its
use was given to each patient, consistent with the New
Zealand Code of Health and Disability Services Con-
sumers’ Rights (Right 6: Right to be fully informed) [19].
SHIVERS surveillance includes that of all hospitali-
zations with SARI to the four hospitals in the study
region (Auckland City Hospital, Middlemore Hospital,
Starship Children’s Hospital, and Kidz First Children’s
Hospital) since May 1, 2012. The population in this
region (n = 905,634), as defined at the 2013 national
census, is diverse with respect to ethnicity (25 %
Asian, 16 % Pacific, 11 % Māori, 47 % European and
other) and socioeconomic status (20 % of sample in
the least deprived quintile of households, 27 % in the
most deprived quintile) [18].
For this CXR severity scoring validation study, we
identified a case series of 250 people with SARI. From
the 926 SARI cases identified during the surveillance
period at two of the SHIVERS surveillance hospitals,
Auckland City and Starship Children’s Hospital, we
stratified the data into two age groups, 0 to 14 years
(children), and 15 years and over (adults). Using random
numbers, we randomly selected 125 children and 125
adults with SARI. To be eligible both a CXR and a naso-
pharyngeal sample had to have been collected. If a SARI
case had more than one CXR recorded, only the first
CXR was included.
Chest radiograph scoring
Following a literature review, and with input from pediatri-
cians, adult physicians and intensivists working within the
SHIVERS project, we devised a five-point CXR scoring tool
to record the severity of lung abnormalities (Fig. 2).
Scoring of chest radiograph images by study radiologists
For the purposes of this study, two radiologists with expert-
ise in interpreting pediatric chest radiographs reviewed the
125 chest radiographs of the pediatric patients and two
radiologists with expertise in interpreting adult chest radio-
graphs reviewed the 125 chest radiographs of adult patients.
These four radiologists formed the ‘study radiologist’ team.
The two pediatric and two adult study radiologists, blinded
to the clinical details of each case, independently read and
assigned a score of 1 to 5 for the 125 CXR images from
children aged 0–14 years and the 125 CXR images from
adults aged 15 years and over.
Reading of chest radiographs by clinical radiologists
Clinical radiologists based at the two hospitals, who
were unaware of this validation study, read the CXR of
each participant as a component of routine clinical care
and then entered a written report of their reading of the
CXR into the patient’s medical record.
Scoring of the clinical radiologists’ chest radiograph
reports by clinicians
For the purposes of this study, we created a clinician
team that included a pediatrician, an internal medicine
physician, a pediatric resident, an internal medicine resi-
dent, two medical students and a research nurse. Each
member of this clinician team independently read all 250
CXR reports written by the clinical radiologists and, using
the same scoring system as had been applied by the four
study radiologists, assigned a score of 1 to 5 for each re-
port (actual radiographs were not reviewed). Clinicians
with considerable experience (attending physicians and
residents), as well as those with more limited experience
(medical students and a research nurse), in reading CXR
reports performed the CXR severity scoring.
We compared the clinicians’ scoring of the clinical ra-
diologists’ chest radiograph report with the reference
scores from the study radiologists’ reading of the chest
radiographs. We also compared clinicians’ scores with
one another, using the pediatrician’s scores as the
clinician reference standard.
Agreement within and between radiologists and clinicians
on chest radiograph scoring
A weighted Kappa (κ) score (weighted by 1-[(i-j)/(1-k)]2)
was used to assessment agreement on chest radiograph
scoring. We compared the scores of, and determined the
agreement between, each pair of study radiologists.
Then, using the most senior of each radiologist pair
(pediatric and adult) as the reference standard, we com-
pared the CXR report scoring of each clinician with the
study radiologist’s score.
Agreement between pairs of study radiologists, of each
clinician with the study radiologists score, and between
pairs of clinicians were then determined. Weighted
Kappa scores and 95 % confidence intervals (CI) were
calculated using StatsDirect statistical software version
2.7.9 (Altrincham, Cheshire, UK). We used a weighted
rather than raw Kappa score as this adjusts for the de-
gree of disagreement when the compared categories are
Fig. 1 World Health Organization severe acute respiratory infection
case definition [2]
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ordinal. Weighted Kappa scores were defined as showing
‘poor’ (κ ≤ 0.2), ‘fair’ (>0.2 to 0.4), ‘moderate’ (>0.4 to
0.6), ‘good’ (>0.6 to 0.8) or ‘very good’ (>0.8 to 1.0) agree-
ment [20].
Following completion of the scoring and identification
of the CXR reports with discrepant scores, the
pediatrician then met individually with each of the other
clinicians to determine if we could achieve a consensus
severity score for these reports. We then recalculated
the κ scores for the radiologist-clinician and clinician-
clinician comparisons.
Sample-size estimates
We based sample-size estimates upon the five-point or-
dinal scale scoring system, assuming a distribution of
scores of 10 %, 25 %, 25 %, 25 %, and 15 % across the
five categories. For a sample-size of 200, the Cohen’s
Kappa measure of agreement will have a confidence
interval in the order of ±0.14 (assuming 100 % agree-
ment and weighting to allow for the ordinal nature of
scores). Given the potential for the actual distributions
across categories to differ from these assumptions we in-
creased the sample-size to 250.
Results
Study sample demographics, clinical illness, respiratory
viral isolates and CXR abnormalities (Table 1)
The median (interquartile range) age of the children
with SARI was 1 (0–3) year of age and of the adults was
60 (42–75) years of age. Sixty-five (50 %) of the adults
were smokers, of whom 18 (28 %) were current smokers.
The most common presenting syndromes among the
children were suspected pneumonia (42 %) and sus-
pected bronchiolitis (36 %), and among the adults were
suspected pneumonia (39 %) and febrile illness with re-
spiratory symptoms (25 %). Median length of hospital stay
for children and adults was 3 days. Ten percent (children
17 %, adults 3 %) required intensive care. Laboratory testing
identified influenza viruses in 23 % of SARI cases and non-
influenza respiratory viruses (respiratory syncytial virus,
rhinovirus, parainfluenza virus types 1–3, adenovirus, or
human metapneumovirus) in 43 %. In 12 (10 %) children
Fig. 2 The chest radiograph severity scoring system
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and one (1 %) adult co-detection of influenza and a non-
influenza virus occurred. The proportion of SARI cases that
were influenza positive was similar for children versus
adults (21 % vs. 25 %, P = 0.43). A larger proportion of
the SARI cases in children, compared to adults, were
positive for non-influenza respiratory viruses (81 %
vs. 25 %, P < 0.001). A larger proportion of the SARI
cases in children, compared to adults were assigned a
principal discharge diagnosis code for a respiratory ill-
ness (95 % vs. 74 %, P < 0.001). The distribution of
CXR scores across the five scoring categories differed
between children and adults (P < 0.001; Fig. 3).
Chest radiograph scoring agreement
Radiologist with radiologist agreement
Agreement within pairs of radiologists who scored the
radiographs was ‘very good’ for the pediatric radiologists
(κ = 0.83) and ‘good’ for the adult radiologists (κ = 0.75)
(Table 2).
Clinician with radiologist agreement
The κ values for agreement of clinicians with radiologists
ranged from 0.49 to 0.69. Agreement of the clinician’s scor-
ing of the CXR reports with the senior radiologists scoring
the CXR images was ‘good’ for the pediatrician (κ = 0.65),
internal medicine physician (κ = 0.68), internal medicine
resident (κ = 0.66), and pediatric resident (κ = 0.69); and
‘moderate’ for the two medical students (κ = 0.53 and 0.56)
and the research nurse (κ = 0.49) (Table 2).
Clinician with clinician agreement
The κ values for agreement between clinician pairs
ranged from 0.63 to 0.85. Agreement between clinician
pairs of their CXR report scoring was ‘very good’ for
Table 1 Demographic, clinical, and respiratory viral
characteristics, and discharge diagnoses of random sample of
250 patients hospitalized with a severe acute respiratory
infection and identified by active surveillance
Children Adults
Variable (n1 = 125) (n2 = 125)
Demographics
Age in years, median (IQRa) 1 (0–3) 60 (42–75)
Male gender, n (%) 70 (56) 66 (53)
Ethnicity, n (%)
European and other 56 (45) 75 (60)
Maori 22 (17) 13 (10)
Pacific 36 (29) 19 (15)
Asian 11 (9) 18 (15)
Self-defined healthb, n (%)
Excellent 51 (42) 11 (9)
Very good 32 (26) 39 (32)
Good 25 (20) 44 (36)
Fair 5 (4) 20 (16)
Poor 10 (8) 9 (7)
Smoking history (adults only)
Ever smoker, n (%) - 65 (50)
Current smoker, n (%) - 18 (14)
Clinical features of SARI illness
Presenting syndromec, n (%)
Suspected acute upper respiratory tract
infection
6 (5) 3 (3)
Suspected croup 4 (3) 0 (0)
Suspected bronchiolitis 42 (36) 0 (0)
Suspected pneumonia 50 (42) 47 (39)
Exacerbation of adult chronic lung disease 0 (0) 11 (9)
Exacerbation of asthma 7 (6) 7 (6)
Exacerbation of childhood chronic lung disease 1 (1) 0 (0)
Respiratory failure 0 (0) 3 (3)
Febrile illness with respiratory symptoms 3 (3) 30 (25)
Other suspected acute respiratory infection 5 (4) 18 (15)
Length of stay in days, median (IQRa) 3 (2–5) 3 (2–6)
Intensive care unit admission, n (%) 21 (17) 4 (3)
Respiratory viral testing and results
Influenza virus identifiedd, n (%) 26 (21) 31 (25)
Non-influenza respiratory virus identifiede, n (%) 80 (81) 27 (25)
Discharge diagnosis categoryf
Respiratory 119 (95) 93 (74)
Table 1 Demographic, clinical, and respiratory viral
characteristics, and discharge diagnoses of random sample of
250 patients hospitalized with a severe acute respiratory
infection and identified by active surveillance (Continued)
Cardiovascular 0 (0) 6 (5)
Infectious diseases 4 (3) 6 (5)
Other organ systems 2 (2) 20 (16)
*IQR = interquartile range
bn1 = 123, n2 = 123
cn1 = 118, n2 = 119. Suspected upper respiratory tract infection includes
coryza and pharyngitis; exacerbation of adult chronic lung disease includes
chronic obstructive lung disease, emphysema, and bronchitis; exacerbation of
childhood chronic lung disease includes bronchiectasis and cystic fibrosis;
febrile illness with respiratory symptoms includes shortness of breath
dn1 = 125, n2 = 124. Child: influenza A (H1N1)pdm09 n = 7, influenza A (H3N2)
n = 9, influenza A (not subtyped) n = 1, influenza B n = 9; Adult: influenza A
(H1N1)pdm09 n = 8, influenza A (H3N2) n = 12, influenza A (not subtyped)
n = 5, influenza B n = 6
en1 = 99, n2 = 109. Child: respiratory syncytial virus n = 49, rhinovirus n = 24,
parainfluenza virus n = 3, adenovirus n = 13, human metapneumovirus n = 5;
Adult: respiratory syncytial virus n = 7, rhinovirus n = 13, parainfluenza virus
n = 2, adenovirus n = 0, human metapneumovirus n = 4
fBased upon ICD principal discharge diagnosis codes
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the pediatrician versus the internal medicine physician
(κ = 0.85) and the pediatrician versus the pediatric
resident (κ = 0.81); and ‘good’ for comparisons be-
tween the pediatrician and the internal medicine
resident (κ = 0.77), medical students (κ = 0.63 and
0.66), and research nurse (κ = 0.75) (Table 3).
Clinician-radiologist agreement and clinician-clinician
agreement following clinician review of chest radiographs
with scoring discrepancies
Following review by clinician pairs of the CXR reports for
which their scores were discrepant, and determination of
whether a consensus score was possible, we recalculated
radiologist-clinician and clinician-clinician agreement.
The radiologist-clinician κ values ranged from 0.59 to
0.70 following this second CXR report review. The
changes in κ values for agreement of the clinicians’ scor-
ing with the radiologists’ scoring following this second
CXR report review were smaller for the pediatrician
(+3), internal medicine physician (−1), internal medicine
resident (−3) and pediatric resident (+1) and larger for
the medical students (+9, +14) and research nurse (+10)
(Table 4). Agreement on CXR report scoring for all
pairs of clinicians following this consensus meeting was
Fig. 3 Distribution of radiologist’s chest radiograph scores for children and adults hospitalized with a serious acute respiratory infection
Table 2 Agreement between radiologists in scoring severe acute respiratory infection CXRs from their reading of the digital CXR
images and agreement in scoring severe acute respiratory infection CXRs: clinicians reading of CXR reports versus radiologists
reading of CXRs
Weighted Kappa Strength of
Health professional (95 % CI) agreementa
Radiologist Agreement
Pediatric radiologists 0.83 (0.65 to 1.00) ‘Very good’
Adult radiologists 0.75 (0.57 to 0.93) ‘Good’
Radiologist-clinician agreement
Radiologist vs. pediatrician 0.65 (0.52 to 0.78) ‘Good’
Radiologist vs. internal medicine physician 0.68 (0.55 to 0.80) ‘Good’
Radiologist vs. internal medicine resident 0.66 (0.53 to 0.78) ‘Good’
Radiologist vs. pediatric resident 0.69 (0.56 to 0.82) ‘Good’
Radiologist vs. medical student 1 0.56 (0.44 to 0.69) ‘Moderate’
Radiologist vs. medical student 2 0.53 (0.40 to 0.66) ‘Moderate’
Radiologist vs. research nurse 0.49 (0.36 to 0.62) ‘Moderate’
aAgreement: weighted Kappa <0.2 = ‘poor’, >0.2 to 0.4 = ‘fair’, >0.4 to 0.6 = ‘moderate’, >0.6 to 0.8 = ‘good’, >0.8 to 1.0 = ‘very good’ agreement
CI = confidence interval
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‘very good’ with κ scores ranging from 0.97 to 0.99
(Table 3).
The distribution of CXR scores skewed more to the
lower (more normal) scores than was anticipated in the
study sample-size calculation. However, across all com-
parisons the κ estimates had average confidence intervals
of ± 0.12 (range ± 0.08 to ± 0.18), which was in keeping
with our sample-size estimate.
Discussion
Using a novel five-point ordinal scoring system, we de-
scribed the agreement of clinicians with radiologists and
between clinicians in the interpretation of CXR abnormal-
ities in patients with SARI. We observed ‘good’ to ‘very
good’ inter-observer agreement between radiologists who
reviewed the original radiographs and applied the scoring
system. Agreement between radiologists and of radiolo-
gists with clinicians was ‘moderate’ to ‘very good’. Inter-
observer agreement between clinicians of various levels of
experience was ‘good’ to ‘very good’. Following a consen-
sus review by clinician pairs of radiograph reports with
discrepant scores, clinician agreement with the radiolo-
gists improved for the clinicians who were less experi-
enced in CXR interpretation and agreement between all
clinician pairs became ‘very good’.
Our study used data collected from 250 prospectively
enrolled SARI cases (125 pediatric; 125 adult) selected
randomly from a larger number of SARI cases identified
Table 3 Agreement between clinician pairs in classification of CXR abnormalities in patients with a severe acute respiratory infection
Number of CXRs with
discrepant scores
Weighted Kappa Strength of n = 250
Clinician-clinician combination (95 % CI) agreementa n (%)
Agreement after independent review
Pediatrician vs. internal medicine physician 0.85 (0.73 to 0.98) ‘Very good’ 39 (16)
Pediatrician vs. internal medicine resident 0.76 (0.63 to 0.88) ‘Good’ 48 (19)
Pediatrician vs. pediatric resident 0.81 (0.68 to 0.95) ‘Very good’ 51 (20)
Pediatrician vs. medical student 1 0.66 (0.53 to 0.78) ‘Good’ 67 (27)
Pediatrician vs. medical student 2 0.63 (0.50 to 0.76) ‘Good’ 70 (28)
Pediatrician vs. research nurse 0.75 (0.62 to 0.88) ‘Good’ 56 (22)
Agreement after combined review of CXRs with discrepant scores
Pediatrician vs. internal medicine physician 0.98 (0.90 to 1.06) ‘Very good’ 3 (1)
Pediatrician vs. internal medicine resident 0.99 (0.87 to 1.12) ‘Very good’ 4 (2)
Pediatrician vs. pediatric resident 0.97 (0.84 to 1.09) ‘Very good’ 5 (2)
Pediatrician vs. medical student 1 0.99 (0.86 to 1.11) ‘Very good’ 3 (1)
Pediatrician vs. medical student 2 0.98 (0.85 to 1.10) ‘Very good’ 3 (1)
Pediatrician vs. research nurse 0.99 (0.86 to 1.11) ‘Very good’ 6 (2)
aAgreement: weighted Kappa ≤0.2 = ‘poor’, >0.2 to 0.4 = ‘fair’, >0.4 to 0.6 = ‘moderate’, >0.6 to 0.8 = ‘good’, >0.8 to 1.0 = ‘very good’ agreement
CI Confidence interval
Table 4 Agreement in classification of CXR abnormalities in patients with a severe acute respiratory infection: clinicians reading of
CXR reports following clinician-clinician review of discrepant scores versus radiologists reading of CXRs
Weighted Kappa Strength of
Radiologist-clinician combination (95 % CI) agreementa
Radiologist vs. pediatrician 0.68 (0.60 to 0.76) ‘Good’
Radiologist vs. internal medicine physician 0.67 (0.59 to 0.76) ‘Good’
Radiologist vs. adult medical resident 0.65 (0.56 to 0.74) ‘Good’
Radiologist vs. pediatric medical resident 0.70 (0.62 to 0.78) ‘Good’
Radiologist vs. medical student 1 0.65 (0.56 to 0.74) ‘Good’
Radiologist vs. medical student 2 0.67 (0.59 to 0.76) ‘Good’
Radiologist vs. research nurse 0.59 (0.48 to 0.69) ‘Moderate’
aAgreement: weighted Kappa ≤0.2 = ‘poor’, >0.2 to 0.4 = ‘fair’, >0.4 to 0.6 = ‘moderate’, >0.6 to 0.8 = ‘good’, >0.8 to 1.0 = ‘very good’ agreement
CI Confidence interval
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by active surveillance within a defined region and study
period. The CXR’s from the children were more severely
abnormal compared to those obtained from adults. The
largest differences in comparisons between the CXR’s
from children and adults were in the proportion with
CXR severity scores of 1 ‘normal’ (pediatric 11 %, adult
56 %) and of 2 ‘shows patchy atelectasis and/or hyperin-
flation and/or bronchial wall thickening’ (pediatric 63 %,
adult 29 %). We postulate that this is due to age-related
differences in lung anatomy, with young children having
smaller airways with increased airway resistance; less
alveoli and reduced alveolar surface area; and a more
elastic and compliant chest wall compared to adults [21].
For large epidemiological studies of SARI, interpret-
ation of CXRs by radiologists is both costly and time
consuming. In contrast with the storage and subsequent
review of a digital CXR image, a CXR report can be
stored as a simple text document and read without the
requirement for sophisticated software. Our approach al-
lows inclusion of CXR data into a numerical data set with-
out the need for complex methods, such as digital
algorithms. Clinical personnel with less specialist training
may use this approach and achieve acceptable levels of
agreement with radiologists and with more experienced
clinicians, especially if the opportunity for reviewing
reports with discrepant scores is included.
A potential weakness of our study is that we have
compared radiologists’ scores from the original CXR im-
ages to clinicians’ scores of the corresponding reports.
However, we felt it was important to show the scoring
tool was valid when applied to CXRs by radiologists,
given that their interpretation is the gold standard.
Establishing that there was agreement between radiolo-
gists was a necessary first step before proceeding with
comparisons between radiologists and clinicians.
With few admissions to intensive care and very few
CXRs with scores of ‘5’, we cannot be sure agreement
for extremely abnormal CXRs is high. However, most of
the disagreement in previously reported studies is in the
mid-range of our categorization system, e.g. the differen-
tiation between bronchiolitis and pneumonia in children
[11]. Our validation was limited to the first CXR of the
hospital admission so may not have included the most
abnormal radiograph from each patient. However, for
surveillance this is most appropriate.
Application of this CXR scoring system allows for an
evaluation of the relationship between the severity of CXR
abnormalities and exposure to factors that potentially pre-
vent respiratory disease, for example, the pneumococcal
conjugate vaccine [22]. It also allows for an evaluation of
the relationship between the severity of CXR changes on
hospital admission and subsequent health care utilization,
for example, intensive care unit admission. Being able to
include numerical data that describes the severity of chest
radiograph abnormalities may allow for increased preci-
sion in the application of tools that use vital sign and la-
boratory abnormalities to assist in clinical decision
making in patients with SARI [23, 24].
Our scoring system is relatively simple and simpler, for
example, to the approach developed for the scoring of
CXRs from patients with chronic respiratory conditions
such as cystic fibrosis [25]. Given that we were describ-
ing an acute respiratory illness we specifically excluded
a description of the presence of chronic disease, non-
respiratory disease and/or complications from this val-
idation study. We believe that separate description and
recording of such abnormalities and of the acute
changes related to SARI is more appropriate.
The inter-observer agreements achieved in this study
were ‘moderate’ (κ <0.4 to 0.6) to ‘very good’ (κ >0.8 to
1.0). This is an acceptable result when compared to
other studies that have examined inter-observer reliabil-
ity in assessing CXRs, for example in adult community-
acquired pneumonia, where κ values were less than 0.50
[10–12]. The inter-observer agreements achieved in this
study also compare favorably with those found when using
the WHO criteria for radiologically confirmed pneumonia
in children to examine the efficacy of pneumococcal con-
jugate vaccines in preventing pneumonia (Kappa = 0.58)
[22]. We postulate that better agreement was reached with
our scoring system because it only required a description
of the presence of abnormalities rather than an interpret-
ation of whether or not these changes identified a specific
syndrome, for example pneumonia or bronchiolitis [26].
Poor agreement between clinicians on the finer details of
chest radiograph interpretation is evident in studies of
both adults and children with community-acquired
pneumonia [26, 27].
Consistent with the published literature, agreement
of clinicians with radiologists and agreement between
clinicians varied with the level of clinician experience
in reading CXR reports [7, 27–29]. Including clinicians
with less clinical experience in CXR interpretation
(medical students and research nurse) and demonstrat-
ing that they could reach reasonable levels of agree-
ment compared with more experienced colleagues,
shows promise for the application of this tool by such
members of research teams.
Our sample was too small to allow us to reliably investi-
gate or describe the chest radiographic features of popula-
tion subgroups defined, for example by presenting
syndrome, intensity of care required, or respiratory viruses
detected. The first two years of SHIVERS surveillance iden-
tified more than 3,500 cases of SARI. As we plan for five
years of surveillance within the SHIVERS project, we antici-
pate that we will have sufficient study power to complete
these important subgroup analyses and will now be able to
include this measure of CXR severity in our analyses.
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Conclusions
Our CXR report scoring tool provides a reliable and
valid method for describing the overall severity of acute
radiographic abnormalities in patients with SARI. This
low-tech, simple, and relatively quick method makes use
of existing information. The information recorded can
easily be included in numerical data sets without requir-
ing transformation via more complex methods. We have
shown that the interpretation of a pre-existing written
radiologist report is an appropriate proxy for film in-
terpretation. To our knowledge, no previous evaluation
of this approach exists. Our study demonstrates that
clinicians with diverse levels of training and experience
can reach adequate agreement when scoring the sever-
ity of CXR abnormalities in SARI. We anticipate that
this scoring tool will facilitate a clear description of the
respiratory characteristics of SARI and will enable epi-
demiological comparisons between SARI populations
from different countries and settings.
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